Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes

Journal of Cardiac Failure

Volumn 10, Issue 2, 2004, Pages 126-131

  Hockensmith, Melinda L ^a   Estacio, Raymond O ^b,e   Mehler, Philip ^c   Havranek, Edward P ^c   Ecder, S Tevfik ^a   Lundgren, Rita A ^d   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

^d Colorado Prevention Center ^*  (United States)

^e Denver Health ^*  (United States)

Author keywords

albuminuria; heart failure; Type 2 diabetes

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RISK FACTOR;

ALBUMINURIA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 3042747118     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.09.003     Document Type: Article

References (44)

1. American Diabetes Association. Diabetes facts and figures. Available from http://www.diabetes.com. Accessed April 1, 2001.
2. Ho K.K., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol. 22:(Suppl A):1993;6A-13A
3. Kannel W.B., Ho K., Thom T. Changing epidemiological features of cardiac failure. Br Heart J. 72:1994;S3-S9
4. Shindler D.M., Kostis J.B., Yusuf S., Quinones M.A., Pitt B., Stewart D., et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol. 77:1996;1017-1020
5. Gottdiener J.S., Arnold A.M., Aurigemma G.P., Polak J.F., Tracy R.P., Kitzman D.W., et al. Predictors of congestive heart failure in the elderly: The Cardiovascular Health Study. J Am Coll Cardiol. 35:2000;1628-1637
6. Miettinen H., Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakro M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke. 27:1996;2033-2039
7. Ljungman S., Wikstrand J., Hartford M., Berglund G. Urinary albumin excretion - a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens. 9:1996;770-778
8. Schmitz A., Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes: a 10-year follow-up study of 503 patients. Diabetes Med. 5:1988;126-134
9. Gall M.A., Borch-Johnsen K., Hougaard P., Nielsen F.S., Parving H.H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 44:1995;1303-1309
10. Nichols G.A., Hillier T.A., Erbey J.R., Brown J.B. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 24:2001;1614-1619
11. Dries D.L., Exner D.V., Domanski M.J., Greenberg B., Stevenson L.W. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 35:2000;681-689
12. Savage S., Johnson N., Estacio R.O., Feig P.U., MacCarthy P.E., Lukken N.J. The ABCD (Appropriate Blood Pressure Control in Diabetes) Trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes. J Clin Trials. 2:1993;. document 104
13. Estacio R.O., Savage S., Nagel N.J., Schrier R.W. Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial. Control Clin Trials. 17:1996;242-257
14. Estacio R.O., Jeffers B.W., Hiatt W.R., Biggerstaff S., Gifford N., Schrier R.W. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med. 338:1998;645-652
15. Estacio R.O., Jeffers B.W., Gifford N., Schrier R.W. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 23:2000;B54-B64
16. Schrier R.W., Estacio R.O., Esler A., Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 61:2002;1086-1097
17. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs. An extension of the Modified Airlie House Classification: ETDRS report number 10. Ophthalmology. 98:1991;786-806
18. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report no. 12. Ophthalmology. 98:1991;823-833
19. Dyck P.J. Detection, characterization and staging of poly-neuropathy assessed in diabetics. Muscle Nerve. 11:1988;21-32
20. Consensus Panel. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Ann Neurol. 24:1988;99-106
21. Hiatt W.R., Marshall J.A., Baxter J., Sandoval R., Hildebrandt W., Kahn L.R. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epid. 43:1990;597-606
22. Norman J.E., Levy D. Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. J Am Coll Cardiol. 26:1995;1022-1029
23. Jensen T. Micro-albuminuria and large vessel disease in diabetes. J Hypertens Suppl. 10:1992;S21-S24
24. Stehouwer C.D., Lambert J., Donker A.J., van Hinsbergh V.W. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res. 34:1997;55-68
25. Valmadrid C.T., Klein R., Moss S.E., Klein B.E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med. 160:2000;1093-1100
26. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 286:2001;421-426
27. 2-microglobulin in patients with congestive heart failure. J Card Failure. 7:2001;55-63
28. Allbright R., Brensilver J., Cortell S. Proteinuria in congestive heart failure. Am J Nephrol. 3:1983;272-275
29. Capes S.E., Gerstein H.C., Negassa A., Yusef S. Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction. Diabetes Care. 23:2000;377-380
30. Poirier P., Bogaty P., Garneau C., Marois L., Pumesnil J.G. Diastolic dysfunction in normotensive well controlled type 2 diabetes. Diabetes Care. 24:2001;5-10
31. Sato A., Tarnow L., Parving H. Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 21:1998;1534-1539
32. Galderisi M., Anderson K.M., Wilson P.W.F., Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 68:1991;85-89
33. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 289:2003;2560-2572
34. Reichek N., Devereux R. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 63:1981;1391-1398
35. Brownlee M., Cerami A., Viassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 318:1988;1315-1321
36. Ganguly P.K., Pierce G.N., Dhalla K.S., Dhalla N.S. Defective cardiac sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol. 244:1983;E528-E535
37. Giacomelli F., Weiner J. Primary myocardial disease in the diabetic mouse: an ultrastructural study. Lab Invest. 40:1979;460-473
38. Rodrigues B., Cam M.C., McNeill J.H. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem. 180:1998;53-57
39. Factor S.M., Minase T., Cho S., Fein F., Capasso J.M., Sonnenblick E.H. Coronary microvascular abnormalities in the hypertensive diabetic rat. A primary cause of cardiomyopathy? Am J Pathol. 116:1984;9-20
40. Stone P.H., Muller J.E., Hartwell T., et al., for the MILIS Study Group. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol. 14:1989;49-57
41. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 325:1991;293-302
42. Cohn J.N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310
43. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 316:1987;1429-1435
44. Parving H.H., Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 345:2001;870-878